The Future is Now: Leaders in Ocular Gene Therapy meeting will be held for the first time Wednesday, Oct. 9, preceding the American Academy of Ophthalmology meeting in San Francisco.
“In one afternoon, in a concentrated format, the audience will get an update on what is currently evolving in the field of ocular gene therapy,” course director Kourous A. Rezaei, MD, told Healio/OSN.
The non-CME event is presented in four sessions, with more than 30 speakers and panelists discussing adeno-associated virus manufacturing, regulatory, clinical trial endpoints, subretinal surgery, clinical
Uncategorized